<DOC>
	<DOCNO>NCT00231673</DOCNO>
	<brief_summary>The purpose study evaluate effect topiramate clinical electrophysiological parameter patient diabetic peripheral polyneuropathy . The study also evaluate safety topiramate patient population .</brief_summary>
	<brief_title>A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy</brief_title>
	<detailed_description>This multicenter , double-blind , placebo-controlled study evaluate effect topiramate clinical electrophysiological parameter patient diabetic peripheral polyneuropathy . Patients undergo Baseline Phase taper pain medication , diabetes control eligibility reassess . Patients randomize receive either topiramate placebo enter Double-Blind Phase , consist Titration Period ( topiramate dose titrate 25mg/day 200mg/day 42 day ) Maintenance Period ( study medication continue 12 week ) . After Double-Blind Phase , study medication taper Taper Phase , whose duration vary depend patient . The evaluation include electrophysiological assessment , quantitative sensory assessment , clinical assessment subjective pain scale . Safety evaluation ( vital sign , clinical laboratory evaluation , physical neurological examination , evaluation adverse event ) conduct trial . During first 42 day , dos topiramate gradually increase achieve target dose ( 200mg daily mouth ) , dose maintain 12 week , dose slowly reduce stop 12 week .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Diagnosis type 2 diabetes mellitus Pain least 6 month prior randomization investigator attribute diabetic peripheral polyneuropathy Two set baseline nerve conduction study Quantitative Sensory Testing HbA1c = &lt; 9 % Diabetes control stable regimen Female patient must postmenopausal least 1 year , surgically incapable childbearing , practice abstinence , practice acceptable method contraception ( require negative pregnancy test ) Diagnosis Type 1 diabetes mellitus Polyneuropathy due underlie cause Hospitalization within past 3 month due episode hyper/hypoglycemia Other unstable medical condition History suicidal attempt Exposure experimental drug device within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Diabetic peripheral polyneuropathy</keyword>
	<keyword>Electrophysiology</keyword>
	<keyword>Nerve Conduction Study</keyword>
	<keyword>Neurological Examination</keyword>
	<keyword>Quantitative Sensory Testing</keyword>
	<keyword>Topiramate</keyword>
</DOC>